Limone sul Garda
Limone sul Garda (Gardesano: ) is a town and "comune" in the province of Brescia, in Lombardy (northern Italy), at the western bank of Lake Garda. History. Despite the presence of famous cultivations of lemons (the meaning of in Italian), the town's name is probably derived from the ancient (elm) or (Latin: boundary, referring to the communes of Brescia and the Bishopric of Trento). Between 1863 and 1905 the denomination of the comune was Limone San Giovanni. On 13 September 1786, the famous German poet J. Wolfgang Goethe passed by the village by boat and described with  this words its lemon gardens: Until the 1940s, the town was reachable only by lake or through the mountains, with the road to Riva del Garda being completed in 1932, but today Limone is one of the most renowned tourist resorts in the area. Municipal government. Limone is headed by a mayor (') assisted by a legislative body, the ', and an executive body, the '. Since 1995 the mayor and members of the ' are directly elected together by resident citizens, while from 1945 to 1995 the mayor was chosen by the legislative body. The ' is chaired by the mayor, who appoints others  members, called '. The offices of the ' are housed in a building usually called the ' or "". Since 1995, the mayor of Limone is directly elected by citizens, originally every four, then every five years. The current mayor is Antonio Martinelli, elected on 27 May 2019. Health. In 1979, researchers discovered that people in Limone possess a mutant form of apolipoprotein (called ApoA-1 Milano) in their blood, that induced a healthy form of high-density cholesterol, which resulted in a lowered risk of atherosclerosis and other cardiovascular diseases. The protein appears to have given residents of the village extreme longevity - a dozen  of those living here are over the age of 100 (for c. 1,000 total inhabitants). The origin of the mutation has been traced back to a couple who lived in Limone in the 17th century. Research has been ongoing to develop pharmaceutical treatments against heart disease based on mimicking the beneficial effects of the ApoA-1 mutation.